CGTX (Cognition Therapeutics) Sof daromad

CGTX (cogrx.com) - kompaniyaning tovar belgisi

Cognition Therapeutics (CGTX) uchun ushbu kunlik narxlar grafigi yopiq siklli suvni qayta ishlash va emissiyalarni tozalash orqali atrof-muhitga ta'sirni minimallashtiradigan biofarmatsevtika biznesining dinamikasini aks ettiradi. Cognition Therapeutics (CGTX) asab tizimi buzilishlari uchun innovatsion terapiyalarni ishlab chiqishga ixtisoslashgan bo'lib, asosiy ko'rsatkich -0.02 darajasida turibdi. Biroq, klinik sinovlarning yuqori xarajatlari daromadli o'sishni cheklab, foydani zararni qoplashdan oldingi darajada ushlab turibdi.

Sof foyda: Cognition Therapeutics (CGTX) 04.07.2022 - 01.11.2026 uchun

Cognition Therapeutics, Inc. (CGTX) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi cogrx.com|CGTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi Cognition Therapeutics, Inc.|CGTX - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga sof aktivlar qiymati Cognition Therapeutics|CGTX - Balans kapitallashuvi|Bozor qiymatining xususiy kapitalga nisbati cogrx.com|CGTX - Kompaniyaning jami aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning xususiy kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Cognition Therapeutics Inc.|CGTX - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Cognition Therapeutics, Inc.|CGTX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Cognition Therapeutics|Shoshilinch likvidlik cogrx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CGTX - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:cogrx.com - CGTX
Cognition Therapeutics, Inc. brendining mahsuloti

Bozor qiymati Altsgeymer kasalligi terapiyasi muvaffaqiyatiga bog'liq bo'lgan Cognition Therapeutics (CGTX) uchun moliyaviy natijalarni tahlil qilish juda muhimdir. Ushbu ko'rsatkich barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin qolgan sof mablag'larni o'lchaydi. Kompaniyaning joriy sof foydasi -0.02 miqdorini tashkil etadi. Ushbu grafik investorlarga spekulyativ shovqinlarni haqiqiy kapital boshqaruvi samaradorligidan ajratish imkonini beradi. Bu yerdagi salbiy tendentsiyalar tashqi investitsiyalarga yuqori bog'liqlikdan dalolat beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD - Kompaniyaning sof daromadi|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Yillik sof foyda Viking Therapeutics Corp|SUPN - Kompaniyaning sof foydasi|CPRX (catalystpharma.com) - Kompaniya foydasi|DNLI: Sof foyda|HRMY - Sof moliyaviy natija|Sof daromad BHVN|AMLX (Amylyx Corp) - Soliqlar to‘langandan keyingi foyda|Sof foyda TRVI|Sof moliyaviy natija praxismedicines.com|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA - Kompaniyaning sof foydasi|ALEC (Alector, Inc.) - Kompaniya foydasi|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|Sof daromad NGNE|ACIU (AC Immune S.A.) - Soliqlar to‘langandan keyingi foyda|Sof foyda VYGR|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|Yakuniy foyda IKT (Inhibikase Therapeutics Inc)|SAVA: Sof foyda|Assertio (ASRT) - Sof foyda|Kompaniyaning sof foydasi Coya Therapeutics Inc|VistaGen Therapeutics Inc - Soliqdan keyingi foyda|Sof foyda OVID|ABOS - Kompaniyaning sof daromadi|CervoMed Inc - Sof daromad|Sof foyda Alterity Therapeutics Ltd. ATHE|CLNN: Sof daromad|PepGen Inc. - Soliqlar to‘langandan keyingi foyda|JUNS: Sof foyda|RLMD - Sof moliyaviy natija|ANVS (Annovis Bio Corp) - Sof foyda|Sof daromad Grace Tx (GRCE)|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Sof daromad|MetaVia, Inc. - Sof foyda|Yillik sof foyda NeurAxis Inc (NRXS)|HSDT (heliusmedical.com) - Sof daromad|PASG: Soliqlar to‘langandan keyingi foyda|Sof daromad NEUP|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Sof foyda ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|PTIX: Sof daromad|KTTA - Sof foyda|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Avenue Therapeutics Inc - Yakuniy foyda|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof foyda CHRO|Sof daromad eliemtx.com ELYM|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Longboard (LBPH) - Kompaniyaning sof daromadi|Marinus Pharmaceuticals - Sof foyda|Yillik sof foyda nkgenbiotech.com (NKGN)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniya foydasi SAGE|SNPX (Neurotrope) - Sof foyda|Trevena Inc (TRVN) - Sof moliyaviy natija|Sof daromad VIGL (Vigil Neuroscience)|Soliqlar to‘langandan keyingi foyda WENA|Sof foyda CERE (Cerevel Therapeutics, Inc.)